dr. weber on duration of checkpoint inhibitor therapy in melanoma
Published 5 years ago • 430 plays • Length 1:58Download video MP4
Download video MP3
Similar videos
-
1:05
dr. weber on the future of checkpoint inhibitors in melanoma
-
1:03
dr. weber on risk and benefits with immunotherapy combos in melanoma
-
0:49
dr. weber on emerging therapies in melanoma
-
2:25
dr. weber on discontinuing immunotherapy in melanoma
-
7:44
melanoma: considerations in checkpoint inhibition
-
12:12
immune checkpoint proteins
-
38:01
melanoma immunotherapy with dr. jedd wolchok
-
1:02:36
cancer revealed: how the immune system sees and destroys tumors, with jeffrey weber
-
4:11
limiting duration of treatment with checkpoint inhibitors: the data
-
2:06
dr. weber on next steps with pembrolizumab as melanoma treatment
-
1:46
dr. weber on selecting immunotherapy for patients with melanoma
-
1:22
dr. weber on adjuvant pembrolizumab in melanoma
-
1:16
dr. weber on emerging immunotherapy combinations in melanoma
-
5:26
checkpoint inhibitor therapy for treating melanoma
-
1:15
dr. weber on nivolumab in the adjuvant setting for melanoma
-
1:54
jeffrey weber, md, phd, discusses the efficacy of checkpoint inhibitors and immunotherapy
-
0:57
dr. weber on fda approval of pembrolizumab for stage iii melanoma
-
2:05
dr. weber on adjuvant approaches in stage iii melanoma
-
7:51
checkpoint inhibitors: combination therapy in melanoma
-
1:22
dr. weber on nivolumab versus chemotherapy in advanced melanoma
-
7:53
duration of immunotherapy in melanoma
-
1:44
dr. jeffrey weber on optimal therapy sequences in advanced melanoma